Literature DB >> 7669722

Connexin43 reverses the phenotype of transformed cells and alters their expression of cyclin/cyclin-dependent kinases.

S C Chen1, D B Pelletier, P Ao, A L Boynton.   

Abstract

Communication between adjacent cells through gap junctions is believed to be involved in the regulation of cell proliferation. This stems in part from the observation that transfection and overexpression of connexin (cx) 32 or cx43 genes into neoplastic cells lead to normalization of growth and decrease their tumorigenicity. The molecular mechanism(s) responsible for this phenomenon has not been characterized. We transfected the rat cx43 gene into a phenotypically transformed dog kidney epithelial cell line, TRMP, and were successful in restoring gap junctional communication as measured by dye coupling. In addition, cx43-transfected clones reverted to a flat morphology and were sensitive to density-dependent inhibition of proliferation with their G1 and S phase duration almost doubled. These cx43-induced effects were coupled with a decreased expression of specific cell cycle regulatory genes critical to cell cycle progression in nonneoplastic cells including cyclin A, D1, D2, and the cyclin-dependent kinases (CDK) 5 and CDK6. The protein levels of cyclin E, CDK2, and CDK4 were not affected. These results suggest that overexpression of cx43 and the formation of gap junctions with the establishment of gap junctional communication can affect the phenotype of transformed cells and alter specific gene expressions involved in cell cycle regulation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7669722

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  26 in total

1.  Changes in connexin43 expression and localization during pancreatic cancer progression.

Authors:  Joell L Solan; Sunil R Hingorani; Paul D Lampe
Journal:  J Membr Biol       Date:  2012-06-23       Impact factor: 1.843

2.  Polyamines regulate gap junction communication in connexin 43-expressing cells.

Authors:  L Shore; P McLean; S K Gilmour; M B Hodgins; M E Finbow
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

Review 3.  Cardiac to cancer: connecting connexins to clinical opportunity.

Authors:  Christina L Grek; J Matthew Rhett; Gautam S Ghatnekar
Journal:  FEBS Lett       Date:  2014-03-04       Impact factor: 4.124

Review 4.  The role of connexins in prostate cancer promotion and progression.

Authors:  Jarosław Czyż; Katarzyna Szpak; Zbigniew Madeja
Journal:  Nat Rev Urol       Date:  2012-02-21       Impact factor: 14.432

5.  Increased expression of connexins 26 and 43 in lymph node metastases of breast cancer.

Authors:  L Kanczuga-Koda; S Sulkowski; A Lenczewski; M Koda; A Wincewicz; M Baltaziak; M Sulkowska
Journal:  J Clin Pathol       Date:  2006-04       Impact factor: 3.411

Review 6.  The role of connexin-mediated cell-cell communication in breast cancer metastasis.

Authors:  G D Carystinos; A Bier; G Batist
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-10       Impact factor: 2.673

7.  Molecular dynamics and in vitro analysis of Connexin43: A new 14-3-3 mode-1 interacting protein.

Authors:  Darren J Park; Tracey A Freitas; Christopher J Wallick; Carrie V Guyette; Bonnie J Warn-Cramer
Journal:  Protein Sci       Date:  2006-10       Impact factor: 6.725

Review 8.  Implications and challenges of connexin connections to cancer.

Authors:  Christian C Naus; Dale W Laird
Journal:  Nat Rev Cancer       Date:  2010-06       Impact factor: 60.716

9.  Connexin43 reduces melanoma growth within a keratinocyte microenvironment and during tumorigenesis in vivo.

Authors:  Mark J Ableser; Silvia Penuela; Jack Lee; Qing Shao; Dale W Laird
Journal:  J Biol Chem       Date:  2013-12-02       Impact factor: 5.157

10.  Connexin 37 profoundly slows cell cycle progression in rat insulinoma cells.

Authors:  Janis M Burt; Tasha K Nelson; Alexander M Simon; Jennifer S Fang
Journal:  Am J Physiol Cell Physiol       Date:  2008-08-27       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.